HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

485.388

-11.332-2.28%

Number of Gainers:13

Number of Losers:17

Number of Flat:3

PE:- -

High:497.296

Open:496.590

Low:482.380

Close:496.720

Volume:46.26M

Turnover:1.41B

Market Cap:308.34B

Float Cap:274.28B

Loading ...

Hong Kong Stock Movement | OCUMENSION-B (01477) Climbs Over 3% Following NDA Acceptance by Chinese Regulator

Suzhou Basecare Medical Gets Class III Chinese Certification for IVF Embryo Storage Kits

MT Newswires Live

Suzhou Basecare Medical - Basecare-B Obtains Nmpa Class Iii Device Certificates for Gems Vitrification and Warming Sets

THOMSON REUTERS

Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit

Alphamab Oncology-B Completes Share Buyback Worth Approximately HK$967,000

Groundbreaking for Lingyu Pharma's Advanced Complex Injection Facility Aims to Elevate 'Made in China' to Global Standards

Shanghai Kehua Bio-Engineering Secures Regulatory Approvals for Two New Diagnostic Kits

After a One-Day Surge Turns Sour: Hua Bao's Pharma ETF and HK Connect Innovative Drug ETF Experience a Pullback, Yet Strong Fundamentals Remain—Data Releases and Outbound Licensing Momentum Continue to Provide Support

AI Drug Discovery Firm Founded by Shanghai Jiao Tong University Professor Secures Series C1 Funding, a Global First

GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15

ZYLOXTB (02190) Spends Approximately HK$1.13 Million on Share Buyback on September 15

HK Stocks in Focus: HEART CARE-B Surges Over 5% on Robust H1 Growth and A-Share Listing Plans

Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate

Channel Edge Fades, Active Research Lags: Who Can Fill ICBC Credit Suisse's Equity Gap?

Jefferies Reaffirms Bullish Stance on AKESO, Sets Price Target at HK$226

Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine

Hong Kong Stock Flash | TYK Medicines-B (02410) Surges Over 10% as Major Shareholder's Buyback Lifts Sentiment, Following Key Drug Approval

Jefferies Highlights Positive HARMONi-2 Results for AKESO, Reaffirms Buy Rating with HK$226 Target

GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":485.3878,"timestamp":1789537696095,"preClose":496.71994,"halted":0,"volume":46258106,"delay":0,"changeRate":-0.022814,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-11.332153,"latestTime":"09-16 13:48:19","open":496.59045,"high":497.2955,"low":482.37997,"amount":1411742513,"amplitude":0.030028,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789546200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":3.69899,"peRate":164.598608,"turnoverRate":0.00176,"increases":13,"decrements":17,"flats":2,"marketCap":308337303200,"floatMarketCap":274283970712},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":497.2955,"amplitude":0.030028,"preClose":496.71994,"low":482.37997,"pbRate":"3.69899","latestPrice":485.3878,"volume":46258106,"delay":0,"open":496.59045,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":512.388,"twentyDayClose":492.831,"sixtyDayClose":437.952,"secType":"PLATE","market":"HK","turnoverRate":0.00176,"peRate":164.598608,"marketCap":308337303200,"floatMarketCap":274283970712,"timestamp":1789537696095,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":13,"down":17,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184932818","title":"Hong Kong Stock Movement | OCUMENSION-B (01477) Climbs Over 3% Following NDA Acceptance by Chinese Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1184932818","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184932818?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:24","pubTimestamp":1789525456,"startTime":"0","endTime":"0","summary":"OCUMENSION-B (01477) saw its shares rally more than 3% in early trading, last up 1.78% at HK$5.435 with turnover reaching HK$1.3189 million. The surge comes after the company announced a significant...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","VXUS","KCAI","BK1574","IPOS","BK4585","01477","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667676510","title":"Suzhou Basecare Medical Gets Class III Chinese Certification for IVF Embryo Storage Kits","url":"https://stock-news.laohu8.com/highlight/detail?id=2667676510","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667676510?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:50","pubTimestamp":1789523423,"startTime":"0","endTime":"0","summary":"Suzhou Basecare Medical  has received Class III certification in China for its medical devices used for in vitro fertilization and embryo storage, according to a Tuesday Hong Kong bourse filing.The company said China's National Medical Products Administration issued the Guo Xie Zhu Jin 20263180326 and Guo Xie Zhu Jin 20263180338 certificates for its Gems Vitrification-Warming Set.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1222","BK1574","BK1597","02170"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765640","title":"Suzhou Basecare Medical - Basecare-B Obtains Nmpa Class Iii Device Certificates for Gems Vitrification and Warming Sets","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765640?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:44","pubTimestamp":1789479849,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570NF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02170","BK1574","BK1597","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140666287","title":"Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=1140666287","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140666287?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:06","pubTimestamp":1789473999,"startTime":"0","endTime":"0","summary":"Jiangsu Cowin Biotech Co.,Ltd. (SH: 688426) has announced that its wholly-owned subsidiary, Jiangsu Jianwei Diagnostic Technology Co., Ltd., has received the Class III Medical Device Registration...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","MDEV","MEDX","159883","AGNG","IEIH","HART","BK1583","BK0239","BK1100","LGHT","PCR","688426","RSPH","09996","GDOC","PTH","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125751408","title":"Alphamab Oncology-B Completes Share Buyback Worth Approximately HK$967,000","url":"https://stock-news.laohu8.com/highlight/detail?id=1125751408","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125751408?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:47","pubTimestamp":1789472820,"startTime":"0","endTime":"0","summary":"Alphamab Oncology-B (09966) announced that on September 15, 2026, it expended approximately HK$967,000 to repurchase 122,000 of its shares.This buyback reflects the company's ongoing capital...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119705098","title":"Groundbreaking for Lingyu Pharma's Advanced Complex Injection Facility Aims to Elevate 'Made in China' to Global Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=1119705098","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119705098?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:41","pubTimestamp":1789472467,"startTime":"0","endTime":"0","summary":"The groundbreaking ceremony for Zhejiang Lingyu Pharmaceutical Co., Ltd.'s (Lingyu Pharma) advanced complex injection project took place on September 15th in Taizhou, Zhejiang Province. Key figures...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178547175","title":"Shanghai Kehua Bio-Engineering Secures Regulatory Approvals for Two New Diagnostic Kits","url":"https://stock-news.laohu8.com/highlight/detail?id=1178547175","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178547175?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:24","pubTimestamp":1789471463,"startTime":"0","endTime":"0","summary":"Shanghai Kehua Bio-Engineering Co., Ltd. (SZSE: 002022) has announced that it, along with its controlled subsidiary Suzhou Tianlong Biotechnology Co., Ltd., has received medical device registration...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","BK0188","BK0239","LGHT","AGNG","BK1100","BK1574","RSPH","09996","002022","GDOC","IEIH","BK1583","HART","BK0028","MEDX","LNGR","MDEV","PTH","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191166040","title":"After a One-Day Surge Turns Sour: Hua Bao's Pharma ETF and HK Connect Innovative Drug ETF Experience a Pullback, Yet Strong Fundamentals Remain—Data Releases and Outbound Licensing Momentum Continue to Provide Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1191166040","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191166040?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:10","pubTimestamp":1789470640,"startTime":"0","endTime":"0","summary":"Following a sharp rally against the broader market, A-share and Hong Kong-listed innovative drug stocks faced a short-term correction on September 15. The underlying indices of Hua Bao's Pharma ETF...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDN","06978","LNGR","159316","BK1574","159992","BK4585","MEDX","BK1161","FLHK","BK4588","BK4550","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167310315","title":"AI Drug Discovery Firm Founded by Shanghai Jiao Tong University Professor Secures Series C1 Funding, a Global First","url":"https://stock-news.laohu8.com/highlight/detail?id=1167310315","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167310315?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:31","pubTimestamp":1789468297,"startTime":"0","endTime":"0","summary":"Today, Yudao Biotech announced the completion of a Series C1 funding round totaling tens of millions of US dollars. The round was co-led by CITIC Capital's top-tier PE arm, Xinchen Capital, and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1191","AIPO","VTHR","QTOC","ARTY","AGIX","CHAT","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150603956","title":"GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1150603956","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150603956?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:52","pubTimestamp":1789465934,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 15, 2026, the company spent HK$1.2956 million to repurchase 50,000 of its own shares.The share buyback represents the company's ongoing commitment to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","BK1515","02595","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194393622","title":"ZYLOXTB (02190) Spends Approximately HK$1.13 Million on Share Buyback on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1194393622","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194393622?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:39","pubTimestamp":1789465143,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has announced that on September 15, 2026, it expended roughly HK$1.13 million to repurchase 55,000 of its own shares.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","02190","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185373312","title":"HK Stocks in Focus: HEART CARE-B Surges Over 5% on Robust H1 Growth and A-Share Listing Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=1185373312","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185373312?lang=en_us&edition=fundamental","pubTime":"2026-09-15 14:26","pubTimestamp":1789453575,"startTime":"0","endTime":"0","summary":"HEART CARE-B (06609) saw its share price climb more than 5% during Hong Kong trading, last up 4.86% at HK$52.20 with turnover reaching HK$2.37 million.The company recently unveiled its interim...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","FRHC","KCE","83188","BK4588","BK4127","BK4585","03130","03188","06609","BK1147","BK1587","83130","IPOS","159982","82846","02827","399300","07233","VXUS","02846","BK1574","REDS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151094926","title":"Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1151094926","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151094926?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:58","pubTimestamp":1789451896,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (09637) rallied sharply in the afternoon, climbing more than 17% at one point. At the time of writing, the stock was up 12.96% to HK$25.98, with turnover reaching HK$36.28...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LABU","09637","BK4588","BK1191","159938","VXUS","09939","BK1574","BK4585","BK1515","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122495500","title":"Channel Edge Fades, Active Research Lags: Who Can Fill ICBC Credit Suisse's Equity Gap?","url":"https://stock-news.laohu8.com/highlight/detail?id=1122495500","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122495500?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:20","pubTimestamp":1789449655,"startTime":"0","endTime":"0","summary":"The greatest moat for bank-affiliated fund firms lies in distribution channels, yet in the long run, that moat only moves products, it cannot substitute for research, talent, or risk...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152384150","title":"Jefferies Reaffirms Bullish Stance on AKESO, Sets Price Target at HK$226","url":"https://stock-news.laohu8.com/highlight/detail?id=1152384150","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152384150?lang=en_us&edition=fundamental","pubTime":"2026-09-15 12:21","pubTimestamp":1789446061,"startTime":"0","endTime":"0","summary":"Jefferies has released a research note indicating that the H-2 study of AKESO's (09926) Ivonescimab has yielded favorable outcomes. The data showed that the interim overall survival (OS) endpoint...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2399975544.HKD","BK1574","LU0540923850.HKD","BK1161","LU2778985437.USD","LU0417516738.SGD","LU0348827113.USD","IE00BPRC5H50.USD","09926","KURE","LU0348735423.USD","LU0348825331.USD","EWH","IE00B5MMRT66.SGD","LU2476274720.SGD","LU0348783233.USD","LU0348767384.USD","LU1720050803.USD","LU0417516571.SGD","LU2476274308.USD","LU2488822045.USD","LU0348766576.USD","LU0417516902.SGD","LU0348784397.USD","LU0634319403.HKD","IE00B543WZ88.USD","LU1794554557.SGD","LU1961090484.USD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124014323","title":"Brokerage Outlook: Medical Device Sectors Face Mixed Dynamics, Low-Value Consumables Shine","url":"https://stock-news.laohu8.com/highlight/detail?id=1124014323","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124014323?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:16","pubTimestamp":1789438610,"startTime":"0","endTime":"0","summary":"According to a research report released by Zheshang Securities Co.,Ltd., the external environment and internal growth drivers across medical device sub-sectors are expected to diverge in the second...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","LNGR","BK1574","MEDX","BK0276","AGNG","BK1583","601878","BK1100","PTH","RSPH","159883","09996","IEIH","GDOC","HART","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168074562","title":"Hong Kong Stock Flash | TYK Medicines-B (02410) Surges Over 10% as Major Shareholder's Buyback Lifts Sentiment, Following Key Drug Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1168074562","media":"Stock News","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168074562?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:08","pubTimestamp":1789438099,"startTime":"0","endTime":"0","summary":"Shares of TYK MEDICINES-B (02410) climbed steadily higher this morning, trading up 10.1% at HK$3.38 by the time of writing, with turnover reaching HK$3.89 million.According to the latest data from...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","09939","BK1515","159938","BK1574","BK4585","KCAI","BK1161","VXUS","02410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126314596","title":"Jefferies Highlights Positive HARMONi-2 Results for AKESO, Reaffirms Buy Rating with HK$226 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1126314596","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126314596?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:00","pubTimestamp":1789437625,"startTime":"0","endTime":"0","summary":"Jefferies has released a research report indicating that AKESO (09926) achieved positive results from its HARMONi-2 study of Ivonescimab. The data showed that the interim overall survival (OS)...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","LU0540923850.HKD","LU1720050803.USD","LU1961090484.USD","LU0348735423.USD","LU2476274308.USD","LU0348767384.USD","KURE","LU0417516902.SGD","LU2488822045.USD","IE00B5MMRT66.SGD","LU2778985437.USD","LU0348783233.USD","BK1161","LU0561508036.HKD","09926","LU0348766576.USD","LU2399975544.HKD","LU0348827113.USD","LU1794554557.SGD","IE00B543WZ88.USD","LU0348825331.USD","LU2476274720.SGD","BK1574","LU0348784397.USD","IE00BPRC5H50.USD","LU0634319403.HKD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110963745","title":"GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1110963745","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110963745?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:28","pubTimestamp":1789432097,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has unveiled updated efficacy data from its Phase II trial evaluating GFH375 as a monotherapy for patients with pretreated KRAS G12D-mutant non-small cell lung cancer (NSCLC). The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","02595","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184266083","title":"Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1184266083","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184266083?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430067,"startTime":"0","endTime":"0","summary":"The 2026 World Conference on Lung Cancer (WCLC) taking place in Seoul from September 12-15 has become a major catalyst for Chinese innovative drug developers, with a record number of clinical data...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","BK1183","BK1191","LU1008478684.HKD","01911","LU1813983027.USD","BK1161","LNGR","IBBQ","06978","LU0140636845.USD","IE00BZ08YT58.USD","LU1951186391.HKD","BK4588","CDMO","LU1226287792.SGD","LU0501845795.SGD","IE0008369823.USD","02889","BK4139","159992","BK1515","BK1539","BK1521","LU1226288170.HKD","LU0067412154.USD","02238","SG9999004220.SGD","IE00B543WZ88.USD","HK0000165453.HKD","IE0008368742.USD","LU1152091168.USD","LU1226287875.USD","LU0315179316.USD","MEDX","LU1993786604.SGD","LU0880133367.SGD","LU0314109678.HKD","LU1226287529.USD","LU1226288253.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","BK1147","BK4585","IE00BZ08YR35.GBP","KCAI","BK1574","LU1807302812.USD","LU1960683339.HKD","BK1119","LU2039709279.SGD","LU0072913022.USD","KURE","VXUS","01093","BK1144","IE00B5MMRT66.SGD","LU1328277881.USD","IE00B031HY20.USD","06871"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":1,"totalSize":231,"code":"91000000","status":"200"}]}}